BIOCRYST PHARMACEUTICALS INC (BCRX)
8 tracked managers currently hold BCRX on their latest filing. Change is versus that manager’s previous filing. Reported as of quarter end, filed up to ~45 days later, not live positions.
Sort: Size Weight change
Sorted by reported value on the latest filing.
| Manager | Period | Change | Value | Weight | Prev weight | Shares | Δ shares |
|---|---|---|---|---|---|---|---|
| TWO SIGMA INVESTMENTS, LP | Q3 2026 | ADD | $60.0M | 0.0 % | 0.1 % | 7,202,757 | +427,408 |
| RENAISSANCE TECHNOLOGIES LLC | Q3 2026 | TRIM | $17.2M | 0.0 % | 0.0 % | 2,066,160 | -464,130 |
| MILLENNIUM MANAGEMENT LLC | Q3 2026 | TRIM | $9.8M | 0.0 % | 0.0 % | 1,173,266 | -2,221,463 |
| Bridgewater Associates, LP | Q3 2026 | ADD | $7.1M | 0.0 % | 0.0 % | 854,235 | +363,178 |
| CITADEL ADVISORS LLC | Q3 2026 | TRIM | $6.3M | 0.0 % | 0.0 % | 750,364 | -1,008,796 |
| Point72 Asset Management, L.P. | Q3 2026 | ADD | $3.6M | 0.0 % | 0.0 % | 426,306 | +165,389 |
| D. E. Shaw & Co., Inc. | Q3 2026 | TRIM | $2.9M | 0.0 % | 0.0 % | 342,684 | -65,845 |
| TUDOR INVESTMENT CORP ET AL | Q3 2026 | TRIM | $1.0M | 0.0 % | 0.0 % | 120,460 | -74,668 |